Biotech Investors & VC Firms in Colombia
14 firms in this list, with a median first check of $400K. 4 of them lead rounds. Generated from verified public data and updated continuously.
BIOS Ventures
Pre-Seed–Seed
Grupo Alpina innovation platform
Pre-Seed–Seed
Y Combinator
San FranciscoPre-Seed–Series A$500K
111 people
General Atlantic
New YorkSeries B–Late Stage$10M – $1B
500 people
Capria Ventures
SeattleSeed–Growth$300K – $1M
19 people
SoftBank Group
TokyoSeries B–Growth
23 people
Rockstart
AmsterdamPre-Seed–Series B$114.4K – $2.3M
24 people
Advent International
BostonGrowth–Late Stage$1.1B
58 people
Amadeus Capital Partners
LondonPre-Seed–Growth$50K – $12.7M
28 people
Nazca
Mexico CityPre-Seed–Late Stage
32 people
MassChallenge Mexico
BostonPre-Seed–Series A
31 people
D3 Jubilee
SeoulSeed–Series A
11 people
IDB Lab
Washington, D.C.Pre-Seed–Series B
7 people
Syngenta Group Ventures
DurhamSeed–Growth$500K – $5M
6 people
Frequently asked questions
- Who are the top biotech investors & vc firms in colombia?
- Top biotech investors & vc firms in colombia include BIOS Ventures, Grupo Alpina innovation platform, Y Combinator, General Atlantic, Capria Ventures, SoftBank Group, Rockstart, Advent International — 14 firms in total meet the criteria.
- What is the typical first check among biotech investors & vc firms in colombia?
- The median first check among the 14 biotech investors & vc firms in colombia tracked here is $400K.
- How many biotech investors & vc firms in colombia lead rounds?
- 4 of the 14 biotech investors & vc firms in colombia tracked here lead investment rounds.
Related lists
Investors & VC Firms in North America (12952)Investors & VC Firms in United States (11990)Investors & VC Firms in Europe (5859)Investors & VC Firms in Global (4787)AI & Machine Learning Investors & VC Firms (4629)Fintech Investors & VC Firms (4588)SaaS Investors & VC Firms (4239)Healthtech Investors & VC Firms (4227)Enterprise Software Investors & VC Firms (4136)Crypto & Web3 Investors & VC Firms (3986)
Data sourced from public filings and firms' own websites — see our methodology.


















































